Metformina Tevagen

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformina Tevagen (Metformin Hydrochloride)

Q: What is Metformina Tevagen used for?

Metformina Tevagen contains metformin hydrochloride, a Biguanide indicated for the treatment of type 2 diabetes mellitus. It helps lower elevated blood glucose by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues.

Q: How does Metformin Hydrochloride work?

Metformin Hydrochloride inhibits mitochondrial complex I, reducing hepatic gluconeogenesis, and activates AMP‑activated protein kinase (AMPK). This dual action decreases glucose output from the liver and enhances glucose uptake in muscle and fat, leading to lower blood‑sugar levels without increasing insulin secretion.

Q: What is the usual dose of Metformina Tevagen?

The specific dose of Metformina Tevagen is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Typical starting doses range from 500 mg once daily to twice daily, but the exact regimen must be individualized.

Q: Is Metformina Tevagen safe during pregnancy or breastfeeding?

Safety of metformin during pregnancy and lactation is not fully established. It is generally avoided unless the potential benefit justifies the potential risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their physician.

Q: How do I order Metformina Tevagen from GNH India?

To order Metformina Tevagen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does Metformina Tevagen compare with other antidiabetic agents?

Metformina Tevagen (metformin) is the first‑line oral therapy for type 2 diabetes because of its efficacy, low risk of hypoglycemia, and weight‑neutral or modest weight‑loss effect. Compared with sulfonylureas or insulin, it does not stimulate insulin release, reducing hypoglycemia risk, and it has a well‑documented cardiovascular safety profile.

Q: How should Metformina Tevagen be stored and handled?

Metformina Tevagen should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the tablet appears discolored or damaged.

Q: How is Metformina Tevagen administered?

Metformina Tevagen is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing, or splitting unless specifically advised by a healthcare professional.

Q: What are the most serious risks to watch for with Metformina Tevagen?

The most serious adverse events include lactic acidosis, a rare but life‑threatening condition, and severe hypoglycemia when combined with insulin or sulfonylureas. Patients should be alert for symptoms such as unexplained muscle pain, rapid breathing, abdominal discomfort, or marked fatigue, and seek medical attention promptly.

Q: Who should not use Metformina Tevagen?

Metformina Tevagen is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in patients with severe hepatic disease. Caution is also advised in the elderly and those with unstable heart failure.

Metformin Hydrochloride, the active ingredient in Metformina Tevagen, is a Biguanide presented as a 500 mg tablet for oral use. It lowers elevated blood glucose in adults with type 2 diabetes mellitus by reducing hepatic glucose output and improving peripheral insulin sensitivity.

GNH India supplies Metformina Tevagen as a licensed, GDP‑compliant international pharmaceutical product serving hospitals, pharmacies and clinics worldwide, with a focus on reliable quality, regulatory conformity and timely delivery.

Manufacturer / TM Owner

Teva B.V

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformina Tevagen (metformin hydrochloride) is used in the management of disorders related to impaired glucose regulation.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.
Prediabetes (impaired glucose tolerance): helps delay progression to type 2 diabetes when combined with lifestyle modification.
Metabolic syndrome: contributes to weight management and insulin sensitivity as part of a comprehensive treatment plan.

How It Works

Metformin hydrochloride primarily inhibits mitochondrial respiratory-chain complex I, leading to reduced hepatic gluconeogenesis. It also enhances peripheral glucose uptake by activating AMP‑activated protein kinase (AMPK), which improves insulin sensitivity in muscle and adipose tissue, thereby lowering circulating glucose levels without stimulating insulin secretion.

Side Effects

Metformina Tevagen may be associated with a range of adverse reactions, which are generally categorized by frequency and severity.

Common Side Effects

Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite.
Diarrhea: often mild to moderate and transient.
Metallic taste in the mouth.
Weight loss: modest reduction observed in many patients.
Vitamin B12 deficiency: may develop with long‑term therapy.

Serious or Rare Side Effects

Lactic acidosis: a rare but potentially fatal metabolic complication.
Severe hypoglycemia: usually when combined with insulin or sulfonylureas.
Hepatic dysfunction: elevated transaminases in susceptible individuals.
Pancreatitis: infrequent inflammatory reaction of the pancreas.
Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

When prescribing Metformina Tevagen, clinicians should observe several safety considerations to minimize risk.

Renal function assessment: evaluate eGFR before initiation and periodically thereafter.
Hepatic function: avoid use in patients with severe liver disease.
Contraindication in severe renal impairment: do not use if eGFR <30 mL/min/1.73 m².
Monitor blood glucose: adjust dose to avoid hypoglycemia, especially when combined with insulin or sulfonylureas.
Avoid excessive alcohol: increases risk of lactic acidosis.
Store at below 25°C: keep in the original packaging, protect from moisture.

Avoid Interactions

Metformina Tevagen can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

Iodinated contrast agents: may precipitate acute renal failure; pause metformin around the procedure.
Cimetidine: can increase metformin plasma concentrations, raising toxicity risk.
Certain diuretics (e.g., furosemide) in renal impairment: heighten the chance of lactic acidosis.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask symptoms of hypoglycemia.
ACE inhibitors or ARBs: can affect renal function; monitor creatinine and electrolytes.
Alcohol: potentiates lactic acidosis risk, especially with high intake.

Frequently Asked Questions

Metformina Tevagen contains metformin hydrochloride, a Biguanide indicated for the treatment of type 2 diabetes mellitus. It helps lower elevated blood glucose by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues.

Metformin Hydrochloride inhibits mitochondrial complex I, reducing hepatic gluconeogenesis, and activates AMP‑activated protein kinase (AMPK). This dual action decreases glucose output from the liver and enhances glucose uptake in muscle and fat, leading to lower blood‑sugar levels without increasing insulin secretion.

The specific dose of Metformina Tevagen is determined by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Typical starting doses range from 500 mg once daily to twice daily, but the exact regimen must be individualized.

Safety of metformin during pregnancy and lactation is not fully established. It is generally avoided unless the potential benefit justifies the potential risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their physician.

To order Metformina Tevagen, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformina Tevagen (metformin) is the first‑line oral therapy for type 2 diabetes because of its efficacy, low risk of hypoglycemia, and weight‑neutral or modest weight‑loss effect. Compared with sulfonylureas or insulin, it does not stimulate insulin release, reducing hypoglycemia risk, and it has a well‑documented cardiovascular safety profile.

Metformina Tevagen should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the tablet appears discolored or damaged.

Metformina Tevagen is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a glass of water; they are not intended for crushing, chewing, or splitting unless specifically advised by a healthcare professional.

The most serious adverse events include lactic acidosis, a rare but life‑threatening condition, and severe hypoglycemia when combined with insulin or sulfonylureas. Patients should be alert for symptoms such as unexplained muscle pain, rapid breathing, abdominal discomfort, or marked fatigue, and seek medical attention promptly.

Metformina Tevagen is contraindicated in individuals with severe renal impairment (eGFR <30 mL/min/1.73 m²), known hypersensitivity to metformin, acute or chronic metabolic acidosis, and in patients with severe hepatic disease. Caution is also advised in the elderly and those with unstable heart failure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 06 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.